SEC Form 4 · accession 0001513162-16-000742
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis H Titterton Jr.
Director
Period of report
Mar 4, 2016
Accepted (ET)
Mar 8, 2016 · 5:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000715446
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 4, 2016 | P | 500 | $3.31 | A | 497,437 | D |
Table II — derivative securities
No Table II lines on this filing.